Our Enduring Purpose
To fundamentally improve the lives of patients with serious diseases in ways never before possible.
Our powerful IND engine – comprised of our protein library, differentiated screening technologies and protein therapeutic generation capabilities – is unmatched.
Our robust pipeline of novel protein therapeutics is expanding while simultaneously progressing into late-stage development.
We focus on scientific innovation, embracing our entrepreneurial spirit and encouraging teamwork.
Five Prime Therapeutics Presents Data from Safety Lead-in to Phase 3 FIGHT Trial of Bemarituzumab at 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium